Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Protocol for the Illumigene® Mycoplasma Direct Assay

NCT02511262 is registered in ClinicalTrials.gov with Meridian Bioscience, Inc. as lead sponsor.

NCT NCT02511262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02511262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Protocol for the Illumigene® Mycoplasma Direct Assay
Lead sponsor
Meridian Bioscience, Inc.
Phase
Observational
Overall status
Completed
Start date
August 31, 2015
Completion date
Not reported
Enrollment
471 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mycoplasma pneumoniae